Effect of growth hormone on the distribution of decorin and biglycan during odontogenesis in the rat incisor.
Previous studies have shown that growth hormone can influence the expression of N-acetylgalactosamine-containing molecules in the extracellular matrix of developing rat incisors. N-acetylgalactosamine is a principal component of proteoglycans containing chondroitin sulfate and dermatan sulfate, as well as of some glycoproteins. Since chondroitin sulfate proteoglycans are identifiable components in enamel, dentin, and cementum, we have tested the hypothesis that growth hormone modulates their expression in developing rat incisors. The distribution of the chondroitin-sulfate-rich proteoglycans, decorin and biglycan, was investigated. We used the Lewis dwarf rat as a model because their circulating growth hormone levels are markedly reduced. Polyclonal antibodies against decorin and biglycan were used to localize these two proteoglycans. Semi-quantitative assessments of the staining patterns and intensities were made for each proteoglycan within compartments of the developing teeth. In normal Lewis rats, decorin and biglycan differentially expressed throughout the enamel organ, dental papilla, and dental follicle. Decorin displayed a wide distribution throughout all three regions and was closely associated with different cellular components. In contrast, biglycan showed little association with cells and was identified in the predentin and osteoid matrices. The expression of both proteoglycans was dramatically decreased in the growth-hormone-deficient animals. Administration of growth hormone to the dwarf rats markedly elevated the expression of both proteoglycans, approximating the distribution and intensity of staining seen in normal animals. These findings confirm that growth hormone status can modulate the expression of decorin and biglycan, and hence matrix deposition, in the rat tooth.
D000818:Animals; D058578:Biglycan; D058575:Decorin; D016326:Extracellular Matrix Proteins; D013006:Growth Hormone / Q000494:pharmacology*; D007150:Immunohistochemistry; D007180:Incisor / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D009805:Odontogenesis / Q000187:drug effects* / Q000502:physiology; D011509:Proteoglycans / Q000187:drug effects* / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D011917:Rats, Inbred Lew; D011994:Recombinant Proteins / Q000494:pharmacology; D013194:Staining and Labeling
C546886:Bgn protein, rat; D058578:Biglycan; C546880:Dcn protein, rat; D058575:Decorin; D016326:Extracellular Matrix Proteins; D011509:Proteoglycans; D011994:Recombinant Proteins; D013006:Growth Hormone